---
figid: PMC3040966__cbt1005_0430_fig004
figtitle: Working model for the role of WRN in the signaling pathways involved in
  pancreatic cancer cells
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3040966
filename: cbt1005_0430_fig004.jpg
figlink: /pmc/articles/PMC3040966/figure/F4/
number: F4
caption: A working model for the role of WRN in the signaling pathways involved in
  pancreatic cancer cells. The epidermal growth factor receptor (EGFR) pathway is
  a key mediator of cellular proliferation and survival in exocrine pancreas and pancreatic
  adenocarcinoma. We propose that downregulation of WRN expression by oncogenic K-RAS
  signaling, DNA methyltransferases (DNMTs) or a loss-of-heterozygosity (LOH), contributes
  to cellular proliferation and survival in pancreatic neoplasia by preventing p53-mediated
  transcription of p21CDKN1A and promoting the NF-κB signaling cascade. EGFR, receptor
  dimer; AKT, a serine/threonine-specific protein kinase; DSB, double-stranded DN
  A break; ER K, extracellular-signal related kinases; IKK, IkB kinase; MEK, mitogen-activated
  protein kinase; RAF, a protein serine/threonine protein kinase. →, activates; ⊣,
  inhibits.
papertitle: Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer.
reftext: Stephen G Chun, et al. Cancer Biol Ther. 2010 Sep 1;10(5):430-437.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9490657
figid_alias: PMC3040966__F4
figtype: Figure
redirect_from: /figures/PMC3040966__F4
ndex: 53f1dc89-def3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3040966__cbt1005_0430_fig004.html
  '@type': Dataset
  description: A working model for the role of WRN in the signaling pathways involved
    in pancreatic cancer cells. The epidermal growth factor receptor (EGFR) pathway
    is a key mediator of cellular proliferation and survival in exocrine pancreas
    and pancreatic adenocarcinoma. We propose that downregulation of WRN expression
    by oncogenic K-RAS signaling, DNA methyltransferases (DNMTs) or a loss-of-heterozygosity
    (LOH), contributes to cellular proliferation and survival in pancreatic neoplasia
    by preventing p53-mediated transcription of p21CDKN1A and promoting the NF-κB
    signaling cascade. EGFR, receptor dimer; AKT, a serine/threonine-specific protein
    kinase; DSB, double-stranded DN A break; ER K, extracellular-signal related kinases;
    IKK, IkB kinase; MEK, mitogen-activated protein kinase; RAF, a protein serine/threonine
    protein kinase. →, activates; ⊣, inhibits.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - KRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TP53
  - TP63
  - TP73
  - NFKB1
  - EPHB2
  - MAPK1
  - MAPK3
  - Egfr
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - loh
  - IKKepsilon
  - key
  - IKKbeta
  - Dsor1
  - Mtk
  - p53
  - betaTub60D
  - hth
  - Dif
  - dl
  - Rel
  - Erk7
  - rl
  - dsb
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Cancer
  - Cardiomyopathy
  - Lung cancer
---
